The current leadership team at Foghorn Therapeutics has experience in a variety of industries including pharmaceuticals, asset management, and consulting. They have also been educated at some of the top schools in the world, including Western University and Morgan Stanley. This team is well-equipped to lead the company to success in the years to come.
Adrian Gottschalk
President & CEO
Ben Strain
VP, Investor Relations & Corpo...
Carlos Costa
Chief People Officer
Chong-Hui Gu
VP, CMC & QA
Danette L. Daniels
VP, Protein Degrader Platform
Fanny Cavalié
Chief Strategy & Business Oper...
Kevin Wilson
VP, Chemistry
Marina Nelen
VP, Drug Discovery
Michael Lacascia
Chief Legal Officer
Murphy Hentemann
VP, Program Leadership
Samuel Agresta
Chief Medical Officer
Steven Bellon
Chief Scientific Officer
View all